Improving detection and treatment of small ovarian cancer tumors
Quantitative Fluorescence Imaging-Guided Detection and Targeted Therapy Monitoring Platform for Ovarian Cancer Micrometastases
This study is looking for ways to find and treat tiny tumors in women with advanced ovarian cancer using special imaging and a light-activated drug, which could lead to better results and fewer side effects than regular chemotherapy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University New York Stony Brook NIH-funded |
| Lab location | 1 site (Stony Brook, United States) |
| Project ID | NIH-11078659 on NIH RePORTER |
What this research studies
This research focuses on enhancing the detection and treatment of microscopic tumor nodules in patients with advanced ovarian cancer. By using a combination of advanced imaging techniques and targeted therapy, the study aims to identify these small tumors more effectively and deliver treatment directly to them. The approach involves using a special imaging method that highlights cancer cells and a targeted drug that is activated by light, which can help minimize side effects compared to traditional chemotherapy. Patients may benefit from a more precise treatment that could improve their chances of survival.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with advanced ovarian cancer who have microscopic tumor nodules that are difficult to detect and treat.
Not a fit: Patients with early-stage ovarian cancer or those without detectable micrometastases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for ovarian cancer, potentially improving survival rates and reducing the side effects of chemotherapy.
How similar studies have performed: Other research has shown promise in using targeted therapies and advanced imaging techniques for cancer treatment, indicating that this approach could be effective.
Where this research is happening
Stony Brook, United States
- State University New York Stony Brook — Stony Brook, United States (Active)
Researchers
- Principal investigator: Sunar, Ulas — State University New York Stony Brook
- Study coordinator: Sunar, Ulas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.